Tariquidar

Tariquidar
Clinical data
ATC code	none;
Identifiers
	IUPAC name N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide;
CAS Number	206873-63-4 ;
PubChem CID	148201;
ChemSpider	130650 ;
UNII	J58862DTVD;
ChEMBL	ChEMBL348475 ;
CompTox Dashboard (EPA)	DTXSID10174746 ;
Chemical and physical data
Formula	C38H38N4O6
Molar mass	646.744 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC;
	InChI InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43) ; Key:LGGHDPFKSSRQNS-UHFFFAOYSA-N ;
	(what is this?) (verify)

Tariquidar (INN/USAN) is a P-glycoprotein inhibitor^[1] undergoing research as an adjuvant against multidrug resistance in cancer.

References

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.